 |
Journal articles
Avancées et synthèse des derniers congrès : ASCO-GU, EAU, AUA, ASCO concernant la prise en charge médicale du cancer du rein localement avancé ou métastatique. [Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer]
Jean-Jacques Patard
1, 2, *
Bernard Escudier
3
Philippe Paparel
3
Yann Neuzillet
4
Jean-Alexandre Long
3
Hervé Baumert
3
Jean-Michel Corréas
3
Hervé Lang
5
Laura Poissonnier
3
Nathalie Rioux-Leclercq
2, 6
Michel Soulié
7
*
Corresponding author
Jean-Jacques Patard 1, 2
Correspondent author
Bernard Escudier 3
Author
Philippe Paparel 3
Author
Yann Neuzillet 4
Author
Jean-Alexandre Long 3
Author
Hervé Baumert 3
Author
Jean-Michel Corréas 3
Author
Hervé Lang 5
Author
1
Service d'urologie [Rennes] = Urology [Rennes] (CHU, 2 rue Henri Le Guilloux 35033 Rennes cedex 9 - France)
- Hôpital Pontchaillou (France)
- CHU Pontchaillou [Rennes] (2 Rue Henri le Guilloux, 35000 Rennes - France)
2
IGDR - Institut de Génétique et Développement de Rennes (Faculté de Médecine - CS 34317 2 Av du Professeur Léon Bernard 35043 RENNES CEDEX - France)
- CNRS - Centre National de la Recherche Scientifique : UMR6061 (France)
- UR1 - Université de Rennes 1 (2 rue du Thabor - CS 46510 - 35065 Rennes cedex - France)
- UNIV-RENNES - Université de Rennes (France)
4
Service d'urologie (40 rue Worth - 92150 Suresnes - France)
- Hôpital Foch [Suresnes] (40 Rue Worth 92150 Suresnes - France)
6
Service d'anatomie et cytologie pathologiques [Rennes] = Anatomy and Cytopathology [Rennes] (CHU Rennes, 2, rue Henri-le-Guilloux, 35000 Rennes - France)
- CHU Pontchaillou [Rennes] (2 Rue Henri le Guilloux, 35000 Rennes - France)
7
Service d'Urologie - Transplantation Rénale - Andrologie (Toulouse Cedex - France)
Abstract : During the recent congress of urology and oncology key topics discussed were the evolution of survival data in metastatic kidney cancer which median is now around 40 months, persistent questions about the role of nephrectomy, including access to the systemic treatment of nephrectomized patients and tumor resectability induced by systemic therapies, the emergence of new prognostic models which are adapted to new therapeutic standards, and the emergence of promising new drugs including pazopanib. This article describes these advances.
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-00489823
Contributor : Hervé de Villemeur Connect in order to contact the contributor
Submitted on : Monday, June 7, 2010 - 10:35:10 AM
Last modification on : Wednesday, March 30, 2022 - 2:35:09 PM
Contributor : Hervé de Villemeur Connect in order to contact the contributor
Submitted on : Monday, June 7, 2010 - 10:35:10 AM
Last modification on : Wednesday, March 30, 2022 - 2:35:09 PM
Identifiers
- HAL Id : inserm-00489823, version 1
- DOI : 10.1016/S1166-7087(10)70018-X
- PUBMED : 20493436
Collections
INSERM | CNRS | UNIV-RENNES1 | IGDR | UR1-UFR-SVE | UNIV-RENNES | UR1-BIO-SA
Citation
Jean-Jacques Patard, Bernard Escudier, Philippe Paparel, Yann Neuzillet, Jean-Alexandre Long, et al.. Avancées et synthèse des derniers congrès : ASCO-GU, EAU, AUA, ASCO concernant la prise en charge médicale du cancer du rein localement avancé ou métastatique. [Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer]. Progrès en Urologie, Elsevier Masson, 2010, 20 Suppl 1, pp.S11-5. ⟨10.1016/S1166-7087(10)70018-X⟩. ⟨inserm-00489823⟩
Metrics
Record views